Company Overview
Snapshot
Founded in September 2014 by Moshe Milchman, ARCHIMEDICX operated with 11–50 employees. The company raised $4 million across two funding rounds. In February 2016, ARCHIMEDICX announced a partnership to feature its hospital listings on Mail.ru, a significant move for market expansion.
Business overview
ARCHIMEDICX provides a multilingual portal and support ecosystem designed to offer unbiased information about hospitals globally. The company developed a hospital scoring system and an online search-engine-based platform to assist international patients in finding high-quality hospitals for elective surgeries. Its methodology has been certified by HIMSS Europe, serving the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Patient Engagement, targeting patients, insurance companies, and healthcare providers.
Strategic signal
In February 2016, ARCHIMEDICX partnered with Mail.ru to integrate its hospital listings onto the Russian platform. This collaboration was a strategic move to expand the company's reach into the Russian market, indicating a focus on international growth and validating its hospital search and ranking technology through a major online platform.
Company Intelligence Q&A
- What is ARCHIMEDICX's primary business?
- ARCHIMEDICX operates a multilingual portal and support ecosystem that provides unbiased information about hospitals worldwide, featuring a hospital scoring system and online search engine for patients seeking high-quality hospitals for elective surgeries.
- When was ARCHIMEDICX founded and by whom?
- ARCHIMEDICX was founded in September 2014 by Moshe Milchman.
- What was a key strategic partnership for ARCHIMEDICX?
- In February 2016, ARCHIMEDICX partnered to feature its hospital listings on the Russian platform Mail.ru, aiming to expand its market presence.
- How much capital has ARCHIMEDICX raised?
- ARCHIMEDICX has raised a total of $4 million across two funding rounds.
- What is the status of ARCHIMEDICX?
- ARCHIMEDICX is currently Non Active, having ceased to operate in September 2018.